Rathbones Group’s HUTCHMED HCM Stock Holding History

Rathbones Group’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,450	Closed	-$204K	–	622
2024 Q3	$204K	Hold	10,450	–	–	﹤0.01%	540
2024 Q2	$179K	Hold	10,450	–	–	﹤0.01%	555
2024 Q1	$176K	Hold	10,450	–	–	﹤0.01%	556
2023 Q4	$189K	Hold	10,450	–	–	﹤0.01%	537
2023 Q3	$177K	Hold	10,450	–	–	﹤0.01%	550
2023 Q2	$125K	Buy	+10,450	New	+$143K	﹤0.01%	387
2022 Q1	–	Sell	-9,450	Closed	-$332K	–	429
2021 Q4	$332K	Hold	9,450	–	–	﹤0.01%	351
2021 Q3	$346K	Hold	9,450	–	–	﹤0.01%	341
2021 Q2	$371K	Hold	9,450	–	–	﹤0.01%	340
2021 Q1	$267K	Hold	9,450	–	–	﹤0.01%	351
2020 Q4	$303K	Hold	9,450	–	–	﹤0.01%	329
2020 Q3	$305K	Hold	9,450	–	–	0.01%	309
2020 Q2	$261K	Buy	+9,450	New	+$205K	0.01%	305
2020 Q1	–	Sell	-9,450	Closed	-$237K	–	335
2019 Q4	$237K	Buy	+9,450	New	+$207K	0.01%	294
2019 Q3	–	Sell	-9,450	Closed	-$208K	–	336
2019 Q2	$208K	Buy	+9,450	New	+$270K	0.01%	294

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

CFM

Catalyst Funds Management Sydney NSW, Australia $591M AUM 71.09% 1-Year Est. Return

Rathbones Group's HCM Position: Q4 2024 in Review

Rathbones Group sold out of HUTCHMED (HCM) in Q4 2024, closing a stake of 10,450 shares — an estimated $204K sold.

Rathbones Group first reported a position in HCM in Q2 2019 and held it in 15 quarters. The position peaked at $371K in Q2 2021. 69 funds tracked by Wall St. Rank hold HCM as of Q4 2024.

Rathbones Group reported no remaining HUTCHMED position as of Q4 2024 after selling out during the quarter.
Rathbones Group sold 10,450 HUTCHMED shares in Q4 2024, an estimated $204K.
Rathbones Group first reported a position in HUTCHMED in Q2 2019 and held it in 15 quarters.
Rathbones Group's HUTCHMED position peaked at $371K in Q2 2021.
69 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2024.

Based on Rathbones Group's 13F filing for Q4 2024, filed 13 Feb 2025.